宣泰医药(688247.SH)发布前三季度业绩，归母净利润6346万元，同比下降31.45%

Core Insights - Xuantai Pharmaceutical (688247.SH) reported a revenue of 331 million yuan for the first three quarters of 2025, representing a year-on-year decline of 8.59% [1] - The company's net profit attributable to shareholders was 63.46 million yuan, down 31.45% year-on-year [1] - The non-recurring net profit was 53.88 million yuan, reflecting a year-on-year decrease of 36.64% [1] - Basic earnings per share stood at 0.14 yuan [1]